EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ageing and multiple sclerosis

Julija Isačenko, Renata Balnytė

Neurologijos seminarai · 2024

DOI: 10.15388/ns.2024.28.100.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurologijos seminarai, 2024. Verfasst von Julija Isačenko und 1 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in the treatment of multiple sclerosis in recent decades have allowed an increasing number of people to reach advanced age without significant disability. Most disease-modifying drugs are designed to suppress active inflammation and reduce the risk of relapses; however, as patients age, the pathogenetic mechanisms of the disease change, and progression independent of relapse activity (PIRA) begins to prevail. The prolonged duration of drug-induced immunosuppression, combined with age-related comorbidities, may lead to adverse effects. In this article, we review age-related changes in multiple sclerosis pathogenesis and the associated treatment challenges.

Zitieren

APA

Isačenko, J., & Balnytė, R. (2024). Ageing and multiple sclerosis. Neurologijos seminarai. https://doi.org/10.15388/ns.2024.28.100.2

Vancouver

Isačenko J, Balnytė R. Ageing and multiple sclerosis. Neurologijos seminarai. 2024. doi:10.15388/ns.2024.28.100.2

BibTeX
@article{Isaenko2024,
  author = {Isačenko, Julija and Balnytė, Renata},
  title = {Ageing and multiple sclerosis},
  journal = {Neurologijos seminarai},
  year = {2024},
  doi = {10.15388/ns.2024.28.100.2}
}
Kostenlos starten →